Research
Lipid levels and major adverse cardiovascular events in patients initiated on statins for primary prevention: an international population-based cohort study protocol
Joseph E Blais, Ralph Kwame Akyea, Annelize Coetzee, Amy HY Chan, Wallis CY Lau, Kenneth KC Man, Jeff Harrison, Esther W Chan, Kebede A Beyene, Ian CK Wong and Stephen Weng
BJGP Open 2021; 5 (1): bjgpopen20X101127. DOI: https://doi.org/10.3399/bjgpopen20X101127
Joseph E Blais
1
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China
BScPharmRalph Kwame Akyea
2
Primary Care Stratified Medicine, Division of Primary Care, University of Nottingham, Nottingham, UK
MB ChB, MPHAnnelize Coetzee
3
School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
MPharmAmy HY Chan
3
School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
PhDWallis CY Lau
1
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China
4
Research Department of Practice and Policy, University College London School of Pharmacy, London, UK
PhDKenneth KC Man
1
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China
4
Research Department of Practice and Policy, University College London School of Pharmacy, London, UK
PhDJeff Harrison
3
School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
PhDEsther W Chan
1
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China
PhDKebede A Beyene
3
School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
PhDIan CK Wong
1
Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China
4
Research Department of Practice and Policy, University College London School of Pharmacy, London, UK
PhDStephen Weng
2
Primary Care Stratified Medicine, Division of Primary Care, University of Nottingham, Nottingham, UK
PhD
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Lipid levels and major adverse cardiovascular events in patients initiated on statins for primary prevention: an international population-based cohort study protocol
Joseph E Blais, Ralph Kwame Akyea, Annelize Coetzee, Amy HY Chan, Wallis CY Lau, Kenneth KC Man, Jeff Harrison, Esther W Chan, Kebede A Beyene, Ian CK Wong, Stephen Weng
BJGP Open 2021; 5 (1): bjgpopen20X101127. DOI: 10.3399/bjgpopen20X101127
Lipid levels and major adverse cardiovascular events in patients initiated on statins for primary prevention: an international population-based cohort study protocol
Joseph E Blais, Ralph Kwame Akyea, Annelize Coetzee, Amy HY Chan, Wallis CY Lau, Kenneth KC Man, Jeff Harrison, Esther W Chan, Kebede A Beyene, Ian CK Wong, Stephen Weng
BJGP Open 2021; 5 (1): bjgpopen20X101127. DOI: 10.3399/bjgpopen20X101127
Jump to section
Keywords
More in this TOC Section
Related Articles
Cited By...
Intended for Healthcare Professionals